{"SPADE_UN_26808": {"Sequence Information": {"Peptide Name": "AEEA-LVTX-8", "Sequence": "XIWLTALKFLGKNLGKHLAKQQLSKL", "Sequence Length": 26, "Biological Activity": ["Anticancer"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Efficient synthesis and anticancer evaluation of spider toxin peptide LVTX-8-based analogues with enhanced stability", "Pubmed ID": "36907048", "Reference": "Bioorg Chem. 2023;134:106451", "Author": "Chi QN, Jia SX, Yin H, Wang LE, Fu XY, Ma YN, Sun MP, Qi YK, Li Z, Du SS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/36907048"}], "SPADE ID": "SPADE_UN_26808", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_23083", "Similarity": 1.0, "Sequence": "IWLTALKFLGKNLGK"}, {"SPADE_ID": "SPADE_UN_23084", "Similarity": 1.0, "Sequence": "IWLTKALKFLGKNLGK"}, {"SPADE_ID": "SPADE_UN_23085", "Similarity": 1.0, "Sequence": "IWLTKALKFLGKNLGK"}], "Hemolytic Activity": "", "Target Organism": "Mouse lymphoma A20(IC50=0.52±0.03µM),Human histiocytic lymphoma U-937(IC50=0.56±0.29µM),Human Lymphoblast Daudi cells(IC50=0.61±0.50µM),Human ovarian adenocarcinoma COC1(IC50=2.09±0.32µM),Human hepatocellular carcinoma HepG2(IC50=6.24±2.56µM),Mouse Hepatoma Hepa1-6(IC50=3.49±0.23µM),Human ovarian carcinoma ES-2(IC50=10.70±0.50µM)"}}}